Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?
Collegium Pharmaceutical Ownership Summary
Collegium Pharmaceutical is owned by 115.72% institutional investors, 1.62% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.28% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.07% of its assets in Collegium Pharmaceutical shares.
COLL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Collegium Pharmaceutical | 115.72% | 1.62% | -17.34% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 26.16% | 11.89% | 61.94% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 5.18M | 16.28% | $181.18M |
| Rubric capital management lp | 2.83M | 8.89% | $98.90M |
| Eventide asset management | 2.39M | 7.52% | $83.65M |
| Vanguard group | 2.23M | 7.00% | $77.90M |
| Renaissance | 1.60M | 5.03% | $55.96M |
| Fuller & thaler asset management | 1.50M | 4.72% | $52.58M |
| Principal financial group | 1.31M | 4.12% | $45.83M |
| State street | 1.29M | 4.07% | $45.27M |
| Invesco | 1.28M | 4.03% | $44.89M |
| Geode capital management | 836.38K | 2.63% | $29.27M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ballast asset management, lp | 114.31K | 1.83% | $4.00M |
| Eventide asset management | 2.39M | 1.38% | $83.65M |
| Third avenue management | 203.40K | 1.34% | $7.15M |
| Rubric capital management lp | 2.83M | 1.12% | $98.90M |
| Emerald advisers | 639.69K | 0.72% | $22.38M |
| Emerald mutual fund advisers trust | 395.66K | 0.71% | $13.84M |
| Summerhaven investment management | 25.75K | 0.52% | $900.92K |
| Uniplan investment counsel | 112.03K | 0.38% | $3.92M |
| Values first advisors | 17.59K | 0.33% | $615.28K |
| Globeflex capital l p | 52.95K | 0.29% | $1.85M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 802.23K | 0.00% | 565.44K |
| Millennium management | 647.83K | 0.01% | 461.91K |
| Two sigma investments, lp | 269.32K | 0.01% | 242.31K |
| Walleye capital | 229.19K | 0.03% | 229.19K |
| Qube research | 320.56K | 0.01% | 225.68K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rubric capital management lp | 2.83M | 1.12% | -331.25K |
| Invesco | 1.28M | 0.01% | -301.90K |
| Eventide asset management | 2.39M | 1.38% | -250.49K |
| J. goldman & co lp | - | - | -243.45K |
| Quantedge capital pte | - | - | -237.75K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Walleye capital | 229.19K | 0.03% | 229.19K | $8.02M |
| Jefferies financial group | 126.56K | 0.02% | 126.56K | $4.43B |
| Winton group | 65.34K | 0.09% | 65.34K | $2.29M |
| Algert global | 57.01K | 0.03% | 57.01K | $2.00M |
| Arrowstreet capital, limited partnership | 33.71K | 0.00% | 33.71K | $1.18M |
Sold Out
| Holder | Change |
|---|---|
| Stephens consulting | -1.00 |
| Lindbrook capital | -2.00 |
| Larson financial group | -2.00 |
| Mendota financial group | -4.00 |
| Ifp advisors | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 232 | 7.91% | 36,812,079 | 7.39% | 115 | 1.00% | 123 | 14.95% | 84 | 6.33% |
| Jun 30, 2025 | 219 | -10.61% | 35,601,778 | -3.13% | 111 | 0.84% | 106 | -2.75% | 83 | -15.31% |
| Mar 31, 2025 | 2 | -99.17% | 369,275 | -99.01% | 1 | 0.01% | 1 | -99.07% | 1 | -98.91% |
| Dec 31, 2024 | 239 | -5.16% | 37,025,520 | -3.74% | 114 | 0.81% | 105 | -25.53% | 93 | 22.37% |
| Sep 30, 2024 | 252 | 8.15% | 38,464,415 | -2.96% | 119 | 0.79% | 141 | 8.46% | 76 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 1.91M | 6.07% | - |
| FullerThaler Behavioral Sm-Cp Eq R6 | 1.37M | 4.34% | 60.94K |
| FullerThaler Behavioral Small-Cap Equity | 1.37M | 4.34% | 60.94K |
| Eventide Gilead N | 1.34M | 4.27% | - |
| Eventide Healthcare & Life Sciences I | 1.29M | 4.08% | - |
| Vanguard US Total Market Shares ETF | 993.93K | 3.09% | - |
| Vanguard Total Stock Mkt Idx Inv | 957.93K | 3.04% | -21.24K |
| iShares Russell 2000 ETF | 773.65K | 2.46% | - |
| Principal SmallCap R5 | 551.90K | 1.75% | - |
| Principal U.S. Small Cap Equity | 551.90K | 1.72% | -16.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 12, 2025 | Fallon John A. | - | Sell | $1.65M |
| Nov 06, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell | $200.52K |
| Nov 06, 2025 | Tupper Colleen | EVP & Chief Financial Officer | Sell | $1.02M |
| Aug 29, 2025 | Smith Thomas B | EVP and Chief Medical Officer | Sell | $671.58K |
| Aug 18, 2025 | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $626.17K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 18 |
| 2024 Q4 | - | - |
COLL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools